338 related articles for article (PubMed ID: 29710517)
1. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
4. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
6. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
7. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.
Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB
J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109
[TBL] [Abstract][Full Text] [Related]
8. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
10. NF-κB Signaling Regulates Epstein-Barr Virus BamHI-Q-Driven EBNA1 Expression.
Verhoeven RJA; Tong S; Zong J; Chen Y; Tsao SW; Pan J; Chen H
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29659505
[TBL] [Abstract][Full Text] [Related]
11. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
You S; Yao K; Cao Y
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
[TBL] [Abstract][Full Text] [Related]
12. A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1996 Nov; 70(11):8204-8. PubMed ID: 8892954
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.
Snudden DK; Smith PR; Lai D; Ng MH; Griffin BE
Oncogene; 1995 Apr; 10(8):1545-52. PubMed ID: 7731709
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Fachiroh J; Paramita DK; Tan IB; Haryana SM; Middeldorp JM
J Clin Microbiol; 2005 Jul; 43(7):3066-73. PubMed ID: 16002393
[TBL] [Abstract][Full Text] [Related]
15. Response of nasopharyngeal carcinoma cells to Epstein-Barr virus infection in vitro.
Lin CT; Kao HJ; Lin JL; Chan WY; Wu HC; Liang ST
Lab Invest; 2000 Aug; 80(8):1149-60. PubMed ID: 10950106
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
Cheung ST; Huang DP; Hui AB; Lo KW; Ko CW; Tsang YS; Wong N; Whitney BM; Lee JC
Int J Cancer; 1999 Sep; 83(1):121-6. PubMed ID: 10449618
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.
Brink AA; Vervoort MB; Middeldorp JM; Meijer CJ; van den Brule AJ
J Clin Microbiol; 1998 Nov; 36(11):3164-9. PubMed ID: 9774558
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.
Feng P; Ren EC; Liu D; Chan SH; Hu H
J Gen Virol; 2000 Oct; 81(Pt 10):2417-2423. PubMed ID: 10993929
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.
Wu CC; Chen MS; Lee TY; Huang TS; Cho DY; Chen JY
Viral Immunol; 2024 Mar; 37(2):115-123. PubMed ID: 38498796
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of KLF5 by EBER1 via the ERK signaling pathway in EBV-positive nasopharyngeal carcinoma cells: implications for latent EBV infection.
Hu J; Xin F; Liu W; Gong Z; Zhang Y; Liu S
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38747699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
